NCT04001725 2019-11-13OPTIMALFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Unknown110 enrolled
NCT00248547 2017-05-09Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantOHSU Knight Cancer InstitutePhase NA Completed40 enrolled 8 charts